Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography

Bone

Volumn 44, Issue 4, 2009, Pages 585-589

  Stevenson, David A ^a,b   Viskochil, David H ^a,b   Carey, John C ^a,b   Slater, Hillarie ^a   Murray, Mary ^a   Sheng, Xiaoming ^a   D'Astous, Jacques ^a,b   Hanson, Heather ^a   Schorry, Elizabeth ^c   Moyer Mileur, Laurie J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bone; Bone mineral content; Neurofibromatosis type 1; Peripheral quantitative computed tomography; Tibia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE BOWING; BONE DENSITOMETRY; BONE DYSPLASIA; BONE MINERAL; BONE RADIOGRAPHY; BONE STRUCTURE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GEOMETRY; HUMAN; LOWER LEG; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PERIOSTEUM; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LEG; MALE; NEUROFIBROMATOSIS 1; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61749087250     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.12.002     Document Type: Article

References (31)

1. Viskochil D. Genetics of neurofibromatosis 1 and the NF1 gene. J. Child Neurol. 17 (2002) 562-570
2. Stevenson D.A., Birch P.H., Friedman J.M., Viskochil D.H., Balestrazzi P., Buske A., et al. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am. J. Med. Genet. 84 (1999) 413-419
3. Vitale M.G., Guha A., and Skaggs D.L. Orthopaedic manifestations of neurofibromatosis in children: an update. Clin. Orthop. 401 (2002) 107-118
4. Friedman J.M., and Birch P.H. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1728 patients. Am. J. Med. Genet. 70 (1997) 138-143
5. Crawford A.H., and Schorry E.K. Neurofibromatosis in children; the role of the orthopaedist. J. Am. Acad. Orthop. Surg. 7 (1999) 217-230
6. Stumpf D.A., Alksne J.F., Annegers J.F., Brown S.S., Conneally P.M., Housman D., et al. Neurofibromatosis conference statement national institutes of health consensus development conference. Arch. Neurol. 45 (1988) 575-578
7. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278 (1997) 51-57
8. Stevenson D.A., Viskochil D.H., Schorry E.K., Crawford A.H., D'Astous J., Murray K.A., et al. The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1. Genet. Med. 9 (2007) 409-412
9. Stevenson D.A., Zhou H., Ashrafi S., Messiaen L.M., Carey J.C., D'Astous J.L., et al. Double inactivation of NF1 in tibial pseudarthrosis. Am. J. Hum. Genet. 79 (2006) 143-148
10. Visnapuu V., Peltonen S., Ellilä T., Kerosuo E., Väänänen K., Happonen R.P., et al. Periapical cemental dysplasia is common in women with NF1. Eur. J. Med. Genet. 50 (2007) 274-280
11. Tucker T., Birch P., Savoy D.M., and Friedman J.M. Increased dental caries in people with neurofibromatosis 1. Clin. Genet. 72 (2007) 524-527
12. Stevenson D.A., Moyer-Mileur L.J., Murray M., Slater H., Sheng X., Carey J.C., et al. Bone mineral density in children and adolescents with neurofibromatosis type 1. J. Pediatr. 150 (2007) 83-88
13. Illes T., Halmai V., de Jonge T., and Dubousset J. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos. Int. 12 (2001) 823-827
14. Kuorilehto T., Pöyhönen M., Bloigu R., Heikkinen J., Väänänen K., and Peltonen J. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos. Int. 16 (2004) 928-936
15. Lammert M., Kappler M., Mautner V.F., Lammert K., Störkel S., Friedman J.M., et al. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos. Int. 16 (2005) 1161-1166
16. Dulai S., Briody J., Schindeler A., North K.N., Cowell C.T., and Little D.G. Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J. Pediatr. Orthop. 27 (2007) 472-475
17. Yilmaz K., Ozmen M., Bora Goksan S., and Eskiyurt N. Bone mineral density in children with neurofibromatosis 1. Acta Paediatr. 96 (2007) 1220-1222
18. Brunetti-Pierri N., Doty S.B., Hicks J., Phan K., Mendoza-Londono R., Blazo M., et al. Generalized metabolic bone disease in neurofibromatosis type 1. Mol. Genet. Metab. 94 (2008) 105-111
19. Siu W.S., Qin L., and Leung K.S. pQCT bone strength index may serve as a better predictor than bone mineral density for long bone breaking strength. J. Bone Miner. Metab. 21 (2003) 316-322
20. Taylor S.J.W.P., Hindmarsh P.C., Lampe F., Odoki K., and Cook D.G. Performance of a new pubertal self-assessment questionnaire; a preliminary study. Paediatr. Perinat. Epidemiol. 15 (2001) 88-94
21. Ainsworth B.E., Haskell W.L., Leon A.S., Jacobs D.R., Montoye H.J., Sallis J.F., et al. Compendium of physical activities: classification of energy cost of human physical activities. Med. Sci. Sports Exerc. 25 (1993) 71-80
22. Stevenson D.A., Moyer-Mileur L.J., Carey J.C., Quick J.L., Hoff C.J., and Viskochil D.H. Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography. J. Musculoskel. Neuron Interact. 5 (2005) 145-149
23. Specker B.L., and Schoenau E. Quantitative bone analysis in children: current methods and recommendations. J. Pediatr. 146 (2005) 726-731
24. Schoenau E. The "functional muscle-bone unit": a two-step diagnostic algorithm in pediatric bone disease. Pediatr. Nephrol. 20 (2005) 356-359
25. Schoenau E. From mechanostat theory to development of the "functional muscle-bone unit. J. Musculoskelet. Neuron Interact. 5 (2005) 232-238
26. Seeman E., and Delmas P.D. Bone quality - the material and structural basis of bone strength and fragility. N. Engl. J. Med. 354 (2006) 2250-2261
27. Heaney R.P. BMD: the problem. Osteoporos. Int. 16 (2005) 1013-1015
28. Prentice A., Parsons T.J., and Cole T.J. Uncritical use of bone mineral density in absorptiometry may lead to size-related artifacts in the identification of bone mineral determinants. Am. J. Clin. Nutr. 60 (1994) 837-842
29. Schoenau E., Neu C.M., Beck B., Manz F., and Rauch F. Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J. Bone Miner. Res. 17 (2002) 1095-1101
30. Frost H.M. Bone "mass" and the "mechanostat". A proposal. Anat. Rec. 219 (1987) 1-9
31. Kolanczyk M., Kossler N., Kühnisch J., Lavitas L., Stricker S., Wilkening U., et al. Multiple roles for neurofibromin in skeletal development and growth. Hum. Mol. Genet. 16 (2007) 874-886